PHAS
Vanguard Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,808,098
| Closed | -$318K | – | 4605 |
|
|
2022
Q3 | $318K | Hold |
1,808,098
| – | – | ﹤0.01% | 4333 |
|
|
2022
Q2 | $1.09M | Sell |
1,808,098
-18,033
| -1% | -$10.8K | ﹤0.01% | 4061 |
|
|
2022
Q1 | $2.41M | Sell |
1,826,131
-8,772
| -0.5% | -$11.6K | ﹤0.01% | 3888 |
|
|
2021
Q4 | $4.79M | Sell |
1,834,903
-39,670
| -2% | -$104K | ﹤0.01% | 3639 |
|
|
2021
Q3 | $5.83M | Buy |
1,874,573
+5,909
| +0.3% | +$18.4K | ﹤0.01% | 3560 |
|
|
2021
Q2 | $6.95M | Buy |
1,868,664
+297,078
| +19% | +$1.11M | ﹤0.01% | 3399 |
|
|
2021
Q1 | $5.44M | Buy |
1,571,586
+809,659
| +106% | +$2.8M | ﹤0.01% | 3484 |
|
|
2020
Q4 | $2.56M | Buy |
761,927
+33,249
| +5% | +$112K | ﹤0.01% | 3597 |
|
|
2020
Q3 | $2.56M | Sell |
728,678
-9,175
| -1% | -$32.2K | ﹤0.01% | 3414 |
|
|
2020
Q2 | $3.39M | Sell |
737,853
-825
| -0.1% | -$3.8K | ﹤0.01% | 3260 |
|
|
2020
Q1 | $2.44M | Sell |
738,678
-2,461
| -0.3% | -$8.14K | ﹤0.01% | 3246 |
|
|
2019
Q4 | $4.53M | Sell |
741,139
-2,494
| -0.3% | -$15.2K | ﹤0.01% | 3201 |
|
|
2019
Q3 | $3.1M | Buy |
743,633
+70,013
| +10% | +$292K | ﹤0.01% | 3294 |
|
|
2019
Q2 | $8.84M | Buy |
673,620
+489,626
| +266% | +$6.42M | ﹤0.01% | 2929 |
|
|
2019
Q1 | $1.75M | Buy |
183,994
+8,000
| +5% | +$76.1K | ﹤0.01% | 3496 |
|
|
2018
Q4 | $544K | Buy |
+175,994
| New | +$544K | ﹤0.01% | 3721 |
|